Abstract An increasing trend in the incidence of allergic diseases including asthma and related morbidity and mortality is observed worldwide during the last decades.
← all excerpts
Nicotine, as a novel tolerogenic adjuvant, enhances the efficacy of immunotherapy in a mouse model of allergic asthma.
1
—
—